You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
2011, Volume 18, Supplement 2
NEWS
Br J Cardiol 2011;18(Suppl 2):s1-s15
Anaemia in chronic heart failure: what constitutes optimal investigation and treatment?
Whilst the prognosis for patients with chronic heart failure (CHF) has improved over the last two decades, many patients suffer with severe limitation from symptoms
NEWS
Br J Cardiol 2011;18(Suppl 2):s1-s15
Anaemia in chronic heart failure – how common is it and what does it mean?
Chronic heart failure (CHF) is one of the major health challenges in the 21st century. As might be expected from a chronic condition, which increases
NEWS
Br J Cardiol 2011;18(Suppl 2):s1-s15
The origins of anaemia in patients with chronic heart failure
We have already seen how anaemia is common in patients with chronic heart failure (CHF) and how it impacts on symptoms and prognosis. Increasingly, anaemia
NEWS
Br J Cardiol 2011;18(Suppl 2):s1-s15
Anaemia treatment in chronic heart failure
The treatment of anaemia in chronic heart failure (CHF) has many parallels with the treatment of anaemia in chronic kidney disease. Two major therapies are
NEWS
Br J Cardiol 2011;18(Suppl 2):s1-s15
Lessons to be learned from recent studies of anaemia management in chronic kidney disease
Anaemia is extremely common in patients with chronic kidney disease (CKD). Causes are multifactorial but erythropoietin deficiency, iron deficiency or diminished availability and chronic inflammation